Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1700034

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Trastuzumab Deruxtecan
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make a comparative assessment of the adequacy of the reasons the (a) National Institute for Health and Care Excellence has been unable and (b) Scottish Medicines Consortium has been able to recommend Enhertu for use on the NHS.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	20959
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes authoritative, evidence-based recommendations for the National Health Service in England on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits. Decisions on the availability of medicines in Scotland are a matter for the devolved administration.</p><p>The NICE published guidance in 2021 and 2023 recommending Enhertu, also known as trastuzumab deruxtecan, for the treatment of NHS patients with HER2-positive breast cancer through the Cancer Drugs Fund, and it is now available to eligible NHS patients in England in line with the NICE’s recommendations.</p><p>The NICE is currently evaluating Enhertu for the treatment of metastatic HER2-low breast cancer, and has not yet published final guidance. Stakeholders have had an opportunity to appeal against the NICE’s draft recommendations, and the NICE will consider any appeals through the established process and publish final guidance in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 15:01:22 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3930 label Biography information for Caroline Lucas

1700037

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Consultants
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of NHS consultants carried out work in the private sector in the most recent financial year for which data is available.
	tabling member constituency	Knowsley
	tabling member printed	Sir George Howarth
	uin	20900
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>The Department does not hold the information requested.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/04/2024 10:23:50 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	481 label Biography information for Sir George Howarth

1700039

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Disability Aids
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what data her Department holds on how many useable mobility aids and equipment are wasted in the NHS each year.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	20866
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>As set out in the Delivering a Net Zero National Health Service report, published in October 2020, the NHS is committed to reducing its environmental impact, including by increasing the reuse and recycling of medical equipment. This commitment is then applied locally, taking into account local priorities, through local Green Plans.</p><p>NHS England also collaborates with the NHS Supply Chain to increase availability of reusable products, and supports local NHS organisations through the publication of guidance and resources to help with implementing changes.</p><p>Furthermore, the Department published the inaugural Medical Technology Strategy in February 2023, which included a focus on improving resource efficiency. The Department’s Design for Life Programme works with industry, the health and care sector, and academic partners to develop medical technology systems that support reuse, remanufacture, and material recovery becoming the default. The Department recognises we will need to define future data requirements and align digital infrastructure to improve the gathering of core data, such as how products are eventually disposed. The Department’s intention is to publish a roadmap later this year, to articulate our relevant findings and plans moving forward.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20867 question first answered 17/04/2024 14:13:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	411 label Biography information for Mr Barry Sheerman

1700068

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Trastuzumab Deruxtecan
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NICE is taking steps to make Enhertu available to the National Health Service to treat incurable HER2-low secondary breast cancer.
	tabling member constituency	South Holland and The Deepings
	tabling member printed	Sir John Hayes
	uin	20865
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently developing guidance for the National Health Service on whether Enhertu can be recommended for routine NHS funding, based on an assessment of the costs and benefits. The NICE was unfortunately unable to recommend Enhertu as a clinically and cost-effective use of NHS resources in its final draft guidance published on 5 March 2024. Stakeholders have had an opportunity to appeal against the NICE’s draft recommendations, and the NICE will consider any appeals through the established process, and will publish final guidance in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 15:03:45 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	350 label Biography information for Sir John Hayes

1700072

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an estimate of changes in numbers of people reporting (a) physical and (b) mental health issues in the week following clock changes in March for British Summer Time in the last three years.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	20905
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>The Department has not made an estimate of the number of people, or changes to the number of people, reporting physical or mental health issues following the clock changes.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 17/04/2024 08:53:48 answering member 4492 label Biography information for Maria Caulfield
	tabling member	1409 label Biography information for Mr Gregory Campbell

1700124

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Protection (Notification) Regulations 2010
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what weighting her department is giving to (a) individual and (b) organisational stakeholder responses to the Health Protection (Notification) Regulations 2010 consultation.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	21001
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>The consultation on the Health Protection (Notification) Regulations 2010 closed in November 2023. As reflected in the published summary of responses, each response was treated equally during analysis, as is the standard approach for consultation response analysis. The Department and the UK Health Security Agency are considering the responses in total, and are grateful for the stakeholders’ engagement on this complex topic. Confirmation of any changes to the regulations will be published in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 17/04/2024 08:55:02 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4048 label Biography information for Caroline Nokes

1700176

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason NHS employees in band 4 are only eligible for pay progression after three years, rather than two years as in other bands.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	21172
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>As part of the 2018 deal, all pay bands underwent a significant amount of structural reform. The reform included reducing the length of time it takes to reach the top of most pay bands, improving pay progression, and removing all overlap between pay bands. As such, the time taken to progress to the top of Band 4 has been reduced from six years to three years. The time taken to progress varies by band. This is to reflect the time needed to develop the knowledge and skills to perform at the top of the relevant band.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/04/2024 08:59:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4532 label Biography information for Derek Thomas

1700249

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sodium Valproate: Compensation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what her planned timetable is for publishing a response to the Hughes Report on compensation for patients damaged by sodium valproate, published 7 February 2024.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	21105
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 16/04/2024 13:36:40 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4418 label Biography information for Justin Madders

1700279

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure hospitals follow the NICE guidelines on Myalgic encephalomyelitis or chronic fatigue syndrome.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	21115
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the National Institute for Health and Care Excellence (NICE). The Department is working with NHS England to develop an e-learning course on myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome, for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. This has involved feedback and input from the ME Research Collaborative Patient Advisory Group. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME. The NICE’s guidance NG206 states that people with ME should undertake a dietetic assessment by a dietitian with a special interest in ME, if they are losing weight and at risk of malnutrition.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 21116 question first answered 17/04/2024 14:04:10 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4436 label Biography information for Cat Smith

1700280

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure hospitals develop treatment pathways for Myalgic encephalomyelitis or chronic fatigue syndrome patients at risk of starvation.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	21116
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the National Institute for Health and Care Excellence (NICE). The Department is working with NHS England to develop an e-learning course on myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome, for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. This has involved feedback and input from the ME Research Collaborative Patient Advisory Group. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME. The NICE’s guidance NG206 states that people with ME should undertake a dietetic assessment by a dietitian with a special interest in ME, if they are losing weight and at risk of malnutrition.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 21115 question first answered 17/04/2024 14:04:11 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4436 label Biography information for Cat Smith